Antigenic Variation among 173 Strains of Type 3 Poliovirus Isolated in Finland during the 1984 to 1985 Outbreak
- 1 August 1988
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 69 (8) , 1941-1948
- https://doi.org/10.1099/0022-1317-69-8-1941
Abstract
Antigenic properties of 128 clinical type 3 poliovirus isolates of the 1984 to 1985 Finland outbreak from 95 persons and 45 strains from sewage water specimens were evaluated using five neutralizing monoclonal antibodies (MAbs) directed against an antigenic site (designated site 1) on VP1 at amino acids 89 to 100. All five MAbs neutralized the type 3 poliovirus strains used in the vaccines, P3/Saukett and P3/Sabin, but none of them neutralized the prototype strain of the outbreak (P3/Finland/23174/84). Forty-six percent of the clinical isolates resembled the prototype strain (class A) while the rest of the isolates were neutralized by one or more of the MAbs (classes B to D). Although an antigenic drift from A to one of the other classes was observed in sequential specimens from several individuals, no clear-cut overall change in the class distribution was found within the 3 months time span of the outbreak. Homogeneous virus populations were isolated from the sewage specimens using a microtitre endpoint dilution method. The last positive sewage specimens which were obtained in January to February 1985 still had a majority of the class A strain. Some of the clinical isolates were also tested using MAbs directed against distinct antigenic sites. These studies showed that strains that gave the same pattern of reactivity with site 1 MAbs could be differentiated using antibodies directed against other sites. Fifteen strains belonging to different antigenic subclasses were subjected to partial RNA sequencing of the genome region coding for antigenic site 1. The antigenic variation was usually, but not always associated with corresponding amino acid substitutions in antigenic site 1. These results indicate that the antigenic sites of type 3 poliovirus vary extensively within a given outbreak and even during replication in a given host. This variation may have both pathogenetic and epidemiological significance.This publication has 14 references indexed in Scilit:
- Detection of poliovirus antigen by enzyme immunoassayJournal of Clinical Microbiology, 1986
- The Nucleotide Sequence of a Type 3 Poliovirus Isolated During a Recent Outbreak of Poliomyelitis in FinlandJournal of General Virology, 1986
- Modulation of humoral response to a 12-amino-acid site on the poliovirus virionJournal of Virology, 1986
- OUTBREAK OF PARALYTIC POLIOMYELITIS IN FINLAND: WIDESPREAD CIRCULATION OF ANTIGENICALLY ALTERED POLIOVIRUS TYPE 3 IN A VACCINATED POPULATIONThe Lancet, 1986
- Antigenic and Molecular Properties of Type 3 Poliovirus Responsible for an Outbreak of Poliomyelitis in a Vaccinated PopulationJournal of General Virology, 1986
- Antigenic and Molecular Evolution of the Vaccine Strain of Type 3 Poliovirus during the Period of Excretion by a Primary VaccineeJournal of General Virology, 1986
- Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination.Proceedings of the National Academy of Sciences, 1983
- Genetic and Antigenic Variation in Type 3 Polioviruses: Characterization of Strains by Monoclonal Antibodies and T1 Oligonucleotide MappingJournal of General Virology, 1982
- Molecular variation of type 1 vaccine-related and wild polioviruses during replication in humansVirology, 1981
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977